In a challenge brought by Johnson & Johnson Consumer Inc. (JJCI), BBB National Programs' National Advertising Division recommended that ASO LLC discontinue its "2x faster healing" claims for its ...
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, ...